Get started
Author

Daiki Fukuma

Observed names: D Fukuma, D. Fukuma, DAIKI FUKUMA, Daiki FUKUMA, Fukuma, Daiki
ORCID: 0000-0002-8494-7052
Observed ORCID: 0000-0002-8494-7052
OpenAlex ID: A5072260480
Identification of HLA-A2- or HLA-A24-Restricted CTL Epitopes Possibly Useful for Glypican-3-Specific Immunotherapy of Hepatocellular Carcinoma
2006 · Hiroyuki Komori, Tetsuya Nakatsura, et al. · Clinical Cancer Research · 175
Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS
2014 · Yoshihiro Yoshitake, Daiki Fukuma, et al. · Clinical Cancer Research · 157
Prevention of Experimental Autoimmune Encephalomyelitis by Transfer of Embryonic Stem Cell-Derived Dendritic Cells Expressing Myelin Oligodendrocyte Glycoprotein Peptide along with TRAIL or Programmed Death-1 Ligand
2005 · Shinya Hirata, Satoru Senju, et al. · The Journal of Immunology · 126
PDF
IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma
2016 · Yuichiro Matsuoka, Hideki Nakayama, et al. · British Journal of Cancer · 125
PDF
Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma
2011 · M Nagata, H Nakayama, et al. · British Journal of Cancer · 87
PDF
Embryonic Stem Cell–Derived Dendritic Cells Expressing Glypican-3, a Recently Identified Oncofetal Antigen, Induce Protective Immunity against Highly Metastatic Mouse Melanoma, B16-F10
2006 · Yutaka Motomura, Satoru Senju, et al. · Cancer Research · 68
PDF
Proliferation Potential-Related Protein, an Ideal Esophageal Cancer Antigen for Immunotherapy, Identified Using Complementary DNA Microarray Analysis
2004 · Yoshihiro Yoshitake, Tetsuya Nakatsura, et al. · Clinical Cancer Research · 67
Genetically Manipulated Human Embryonic Stem Cell-Derived Dendritic Cells with Immune Regulatory Function
2007 · Satoru Senju, Hirofumi Suemori, et al. · Stem Cells · 63
Soluble IL6R Expressed by Myeloid Cells Reduces Tumor-Specific Th1 Differentiation and Drives Tumor Progression
2017 · Hirotake Tsukamoto, Koji Fujieda, et al. · Cancer Research · 53
Involvement of Regulatory T Cells in the Experimental Autoimmune Encephalomyelitis-Preventive Effect of Dendritic Cells Expressing Myelin Oligodendrocyte Glycoprotein plus TRAIL
2007 · Shinya Hirata, Hidetake Matsuyoshi, et al. · The Journal of Immunology · 50
Onodera's prognostic nutritional index correlates with tumor immune environment and survival in patients with oral squamous cell carcinoma undergoing chemoradiotherapy
2020 · Ryoji Yoshida, Shunsuke Gohara, et al. · Translational Oncology · 35
PDF
Cancer prevention with semi-allogeneic ES cell-derived dendritic cells
2005 · Daiki Fukuma, Hidetake Matsuyoshi, et al. · Biochemical and Biophysical Research Communications · 35
Pluripotent stem cells as source of dendritic cells for immune therapy
2010 · Satoru Senju, Shinya Hirata, et al. · International Journal of Hematology · 34
PDF
Enhancement of active MMP release and invasive activity of lymph node metastatic tongue cancer cells by elevated signaling via the TNF-α-TNFR1-NF-κB pathway and a possible involvement of angiopoietin-like 4 in lung metastasis
2016 · Takuya Tanaka, Takahisa Imamura, et al. · International Journal of Oncology · 30
PDF
Multiple Antigen-targeted Immunotherapy With α-Galactosylceramide–loaded and Genetically Engineered Dendritic Cells Derived From Embryonic Stem Cells
2009 · Satoshi Fukushima, Shinya Hirata, et al. · Journal of Immunotherapy · 28
Therapeutic effect of α‐galactosylceramide‐loaded dendritic cells genetically engineered to express SLC/CCL21 along with tumor antigen against peritoneally disseminated tumor cells
2005 · Hidetake Matsuyoshi, Shinya Hirata, et al. · Cancer Science · 27
PDF
Immunotherapy with pluripotent stem cell-derived dendritic cells
2011 · Satoru Senju, Yusuke Matsunaga, et al. · Seminars in Immunopathology · 26
Activation of Antigen-Specific Cytotoxic T Lymphocytes by β2-Microglobulin or TAP1 Gene Disruption and the Introduction of Recipient-Matched MHC Class I Gene in Allogeneic Embryonic Stem Cell-Derived Dendritic Cells
2008 · Yusuke Matsunaga, Daiki Fukuma, et al. · The Journal of Immunology · 25
An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs
2016 · Masatoshi Hirayama, Yusuke Tomita, et al. · OncoImmunology · 20
Sentinel lymph node biopsy reduces the incidence of secondary neck metastasis in patients with oral squamous cell carcinoma
2016 · AKIMITSU HIRAKI, DAIKI FUKUMA, et al. · Molecular and Clinical Oncology · 19
PDF
Factors affecting volume change of myocutaneous flaps in oral cancer
2016 · A. Hiraki, T. Yamamoto, et al. · International Journal of Oral and Maxillofacial Surgery · 16
Salivary duct carcinoma treated with cetuximab-based targeted therapy: A case report
2017 · Kenta Kawahara, Akimitsu Hiraki, et al. · Molecular and Clinical Oncology · 14
PDF
Aberrant expression of serum amyloid A in head and neck squamous cell carcinoma
2009 · Satoru Shinriki, Mitsuharu Ueda, et al. · Journal of Oral Pathology and Medicine · 9
PDF
Three-dimensional volumetric analysis of the efficiency of marsupialization in patients with mandibular dentigerous cysts involving impacted third molars
2022 · Masatoshi Hirayama, Kazushige Inoue, et al. · Journal of Oral and Maxillofacial Surgery Medicine and Pathology · 4
A case of adenomatoid odontogenic tumor-like tumor, unusual benign odontogenic tumor in the maxilla
2014 · Kenta Kawahara, Hideki Nakayama, et al. · Journal of Oral and Maxillofacial Surgery Medicine and Pathology · 4
Works count: 73
Citation count: 1,298
H-index: 19
I10-index: 22
Year
Topic
Type